Boston Scientific Corporation (LON:0HOY)
Market Cap | 117.73B |
Revenue (ttm) | 13.50B |
Net Income (ttm) | 1.83B |
Shares Out | n/a |
EPS (ttm) | 1.23 |
PE Ratio | 64.39 |
Forward PE | 33.55 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 2,485 |
Average Volume | 4,778 |
Open | 103.00 |
Previous Close | 105.56 |
Day's Range | 103.00 - 106.14 |
52-Week Range | 71.88 - 109.09 |
Beta | 0.68 |
RSI | 51.94 |
Earnings Date | Jul 23, 2025 |
About United States Steel
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ... [Read more]
Financial Performance
In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.
Financial StatementsNews

10 stocks favored to gain up to 30% in a sector that has missed this year's rally
All but two of the S&P 500's sectors are up so far in 2025.

This health care stock forming a 'big base breakout' is ready to separate from the pack, charts indicate
David Keller breaks down the charts in Boston Scientific.
Boston Scientific Corporation (BSX) Q2 2025 Earnings Call Transcript
Cramer's Stop Trading: Boston Scientific
Jim Cramer breaks down why he's keeping an eye on shares of Boston Scientific.

Boston Scientific Reports Higher Profit Margins In Q2, Lifts Guidance
Stronger‑than‑expected sales and raised full‑year guidance underscore Boston Scientific Corporation ‘s (NYSE: BSX) momentum—and hint at where its next product wins may come. Boston Scientific on Wedn...

Cramer's Stop Trading: Boston Scientific
Jim Cramer breaks down why he's keeping an eye on shares of Boston Scientific.
Boston Scientific Eyes Breakout On Strong Second Quarter, Guidance
Boston Scientific stock jumped early Wednesday on a strong second-quarter report and guidance for the full year.

Boston Scientific lifts annual profit view on steady heart devices demand
Boston Scientific raised its annual profit forecast on Wednesday, after strong demand for its heart devices helped the U.S. medical device maker beat second-quarter profit estimates.
Boston Scientific Non-GAAP EPS of $0.75 beats by $0.02, revenue of $5.06B beats by $170M

Boston Scientific announces results for second quarter 2025
MARLBOROUGH, Mass. , July 23, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.061 billion during the second quarter of 2025, growing 22.8 percent on a reported...
Earnings Scheduled For July 23, 2025
Companies Reporting Before The Bell • Equinor (NYSE: EQNR) is projected to report quarterly earnings at $0.26 per share on revenue of $24.67 billion. • Thermo Fisher Scientific (NYSE: TMO) is expect...
Boston Scientific Q2 2025 Earnings Preview

How To Trade Boston Scientific Stock Ahead Of Its Upcoming Earnings?
Boston Scientific (NYSE:BSX) is set to announce its earnings on Wednesday, July 23, 2025. In the last five years, BSX stock has shown a positive return on the day after earnings announcements in 60% o...
Boston Scientific Stock Is on Pause. Its Earnings Could Get It Moving Higher Again.

North America Ureteroscopes Market Outlook Report 2018-2033 with an Overview of Key Companies - Boston Scientific, KARL STORZ, Olympus, PENTAX Medical, and Richard Wolf
Explore the "North America Ureteroscopes Market Outlook to 2033" for key insights into the Ureteroscopes market. The report covers annualized market revenues, volume, and average prices across segment...
Boston Scientific gets FDA nod for expanded labeling of Farapulse

Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System
The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation MARLBOROUGH, Mass. , July 7, 2025 /PRNewswire/ -- Boston Scientific...

Boston Scientific announces conference call discussing second quarter 2025 results
MARLBOROUGH, Mass. , July 1, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter...

I'm Buying Dividend Aristocrats At Bargain Basement Prices
Now is an opportune time to focus on income stocks like that offer value and stability amid market volatility. I focus on 2 Dividend Aristocrats that are attractively valued while supporting well-cove...
S&P 500 Surges 1%; New York Manufacturing Activity Tumbles In June
U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 1% on Monday. The Dow traded up 0.80% to 42,536.72 while the NASDAQ climbed 1.51% to 19,699.21. The S&P 500 also rose,...

What's Happening With Boston Scientific Stock?
Boston Scientific (NYSE:BSX) has experienced a stock price increase of over 30% in the last twelve months, greatly exceeding the S&P 500's gain of 9%. This remarkable performance can be credited to th...

US Stocks Higher; Dow Jumps Over 400 Points
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 400 points on Monday. Following the market opening Monday, the Dow traded up 1.02% to 42,629.20 while the NASDAQ clim...

This Boston Scientific Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag...

$100 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
Boston Scientific (NYSE: BSX) has outperformed the market over the past 10 years by 7.78% on an annualized basis producing an average annual return of 18.87%. Currently, Boston Scientific has a marke...

20 stocks bucking bad trends on Wall Street — what might be next for them?
Analysts have been cutting their estimates for companies' sales and profits, but there are always exceptions to trends.